Taiwan Journal of Ophthalmology
Scope & Guideline
Exploring innovative solutions for ocular health.
Introduction
Aims and Scopes
- Ocular Surgery and Techniques:
The journal features research related to surgical interventions including corneal transplantation, cataract surgery, and innovative techniques like femtosecond laser applications. This focus reflects the journal's commitment to enhancing surgical outcomes through new methodologies. - Corneal Diseases and Treatments:
A significant area of research includes corneal diseases such as keratoconus, Fuchs endothelial dystrophy, and infections. The journal publishes studies on management strategies, surgical techniques, and emerging therapies for these conditions. - Retinal Disorders and Innovations:
Research on retinal diseases, including diabetic macular edema and retinal vein occlusion, is prevalent. The journal highlights advancements in treatment modalities, such as intravitreal injections and optical coherence tomography for diagnosis and management. - Pediatric Ophthalmology:
The journal showcases studies addressing congenital eye diseases, retinopathy of prematurity, and other pediatric conditions, focusing on early diagnosis and interventions. - Artificial Intelligence and Big Data in Ophthalmology:
A unique contribution of the journal is its exploration of artificial intelligence applications in ophthalmology, emphasizing data-driven approaches to improve diagnostic accuracy and treatment planning.
Trending and Emerging
- Impact of COVID-19 on Eye Health:
There has been a surge in research examining the effects of COVID-19 on ocular health, including long COVID implications and ocular manifestations related to the virus, highlighting the pandemic's influence on ophthalmology. - Innovative Treatment Modalities:
Emerging therapies such as gene therapy, stem cell applications, and novel pharmacological interventions for retinal diseases are gaining traction, indicating a trend towards cutting-edge treatment strategies. - Artificial Intelligence in Ophthalmology:
The integration of AI and machine learning in diagnosing and predicting outcomes for various eye diseases is increasingly prevalent, showcasing a forward-looking approach in the journal's publications. - Corneal Crosslinking and Biomechanical Studies:
Research on corneal crosslinking and its biomechanical implications for keratoconus treatment is emerging as a critical area of interest, reflecting advancements in corneal disease management. - Telemedicine and Remote Monitoring:
The rise of telemedicine and the use of digital tools for remote patient monitoring and consultations is a growing theme, particularly in response to the challenges posed by the COVID-19 pandemic.
Declining or Waning
- General Ophthalmology Reviews:
There has been a noticeable decrease in general reviews on ophthalmology topics, as the journal shifts towards more specialized studies and innovative treatment methodologies. - Traditional Diagnostic Techniques:
Research focusing on conventional diagnostic methods, such as basic visual acuity tests and standard imaging modalities, appears to be waning as the field increasingly adopts advanced technologies like optical coherence tomography and artificial intelligence. - Elderly Eye Conditions:
While still relevant, the exploration of eye conditions predominantly affecting the elderly, such as age-related macular degeneration, has received less emphasis in recent publications compared to emerging fields and technologies.
Similar Journals
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
Elevating knowledge in the realm of sight.Investigative Ophthalmology & Visual Science (IOVS) is a leading academic journal published by the Association for Research in Vision and Ophthalmology, dedicated to advancing the field of ophthalmology and visual science. With an impressive impact factor and ranking in the Q1 category for both Ophthalmology and Sensory Systems, IOVS is well-respected for disseminating cutting-edge research and innovative discoveries. Established in 1977, this Open Access journal allows for broad accessibility to pioneering studies, fostering collaboration among researchers, clinicians, and students. The journal has consistently maintained high visibility in the academic community, evidenced by its robust rankings in Scopus, including Rank #16 in Ophthalmology. As it continues to pave the way for future developments in the understanding and treatment of ocular diseases, IOVS serves as an invaluable resource for those immersed in the complex field of visual science.
Turk Oftalmoloji Dergisi-Turkish Journal of Ophthalmology
Connecting Research and Clinical Practice in OphthalmologyTurk Oftalmoloji Dergisi - Turkish Journal of Ophthalmology is a premier peer-reviewed publication dedicated to the field of ophthalmology, published by GALENOS PUBL HOUSE. Since its inception in 1997, this Open Access journal has championed the dissemination of high-quality research, fostering an inclusive environment for sharing knowledge and advancements in eye health. With an ISSN of 1300-0659 and an E-ISSN of 2147-2661, the journal serves as a vital resource for researchers, clinicians, and students interested in the latest findings and innovations in ophthalmic sciences. Although its coverage in Scopus has been discontinued since 2017, the journal has garnered a significant rank of 80 out of 114 in the field of Medicine – Ophthalmology, highlighting its relevance and impact within the discipline. Operating out of Istanbul, Turkey, the Turkish Journal of Ophthalmology continues to be a crucial platform for ophthalmologists and researchers to publish their work and advance the understanding of ocular health.
SURVEY OF OPHTHALMOLOGY
Advancing the Frontiers of Eye HealthSURVEY OF OPHTHALMOLOGY is a premier journal published by Elsevier Science Inc, dedicated to advancing knowledge in the field of ophthalmology. With an impact factor reflective of its high-quality research—ranking 7th out of 137 in the Scopus category for medicine and ophthalmology, this journal maintains a prestigious Q1 categorization in its field for 2023. Since its inception in 1956, the journal has provided comprehensive reviews and original articles covering various aspects of ophthalmic research and clinical practice, supporting the ongoing education of researchers, professionals, and students alike. While open access options are not available, the journal remains an essential resource for the latest developments, discoveries, and expert insights that shape the future of eye health. Based in the United States, at STE 800, 230 Park Ave, New York, NY 10169, the journal continues a legacy of excellence in ophthalmology until 2024 and beyond, making it a pivotal element of scholarly discourse in this vital medical discipline.
Ophthalmologie
Exploring Innovations in Eye HealthOphthalmologie is a distinguished journal published by Springer Heidelberg, specializing in the broad and evolving field of ophthalmology. With an ISSN of 2731-720X and an E-ISSN of 2731-7218, the journal serves as a pivotal platform for disseminating cutting-edge research and clinical advancements in the realm of eye health. As of 2023, it ranks in the third quartile (Q3) within both the general medicine and ophthalmology categories, reflecting its substantial contribution to the academic community and the field's knowledge base. The journal aims to foster collaboration among researchers, medical professionals, and students by offering innovative findings that enhance understanding and treatment of ocular diseases. By nurturing high-quality scholarly discussions, Ophthalmologie plays an essential role in the ongoing development of therapeutic strategies and ophthalmic techniques that ultimately benefit patient care globally. This commitment to excellence is evident as it continues to evolve through its convergence from 1992 to 2023, staying relevant in an ever-changing scientific environment.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
Unveiling the Science Behind SightGRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, published by Springer, has established itself as a premier journal in the field of ophthalmology since its inception in 1870. With an ISSN of 0721-832X and an E-ISSN of 1435-702X, this esteemed journal enjoys a notable impact in the research community, ranking Q1 in Ophthalmology and Q1 in Sensory Systems, as per the latest 2023 journal category quartiles. GRAEFES Archive is dedicated to advancing our understanding of ocular health through both clinical and experimental studies, making it an essential resource for researchers, practitioners, and students alike. Its comprehensive scope covers various aspects of ophthalmic science, reflecting its long-standing commitment to quality and excellence. Although it currently operates on a subscription basis, the journal's significant Scopus rankings—24th out of 137 in Ophthalmology—underscore its relevance and influence within the scientific community. Situated in Germany, with its address in the United States, this international journal continues to shape the discourse on vision science and therapeutic innovation.
Augenheilkunde Up2date
Unveiling the Latest in Eye Health Developments.Augenheilkunde Up2date is a pivotal journal in the field of ophthalmology, published by GEORG THIEME VERLAG KG, a renowned publisher known for its commitment to advancing medical knowledge. With its ISSN 1616-9719 and E-ISSN 1616-9735, this journal serves as a vital resource for researchers, professionals, and students interested in the latest developments and nuanced discussions in eye health. Although not available as open access, its curated content offers significant insights into contemporary research, clinical practices, and emerging trends in ophthalmology, thus promoting the continuous professional development of its readers. There is an emphasis on providing comprehensive reviews that encapsulate the pertinent advancements in the field, making it an essential publication for those aiming to enhance their expertise in eye care and vision science.
CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
Pioneering Discoveries for Visionary FuturesCLINICAL AND EXPERIMENTAL OPHTHALMOLOGY is a leading peer-reviewed journal published by Wiley, renowned for its commitment to advancing the field of ophthalmology. With an impressive impact factor reflecting its high-quality research contributions, this journal is ranked in the Q1 category both in Medicine (miscellaneous) and Ophthalmology, signifying its crucial role in shaping contemporary ophthalmic research. It boasts a remarkable position in the Scopus Ranks, standing at Rank #13 out of 137 in the field of Medicine and Ophthalmology, placing it within the 90th percentile among its peers. Having been in circulation since 1979, this journal encompasses a broad scope of topics that aim to disseminate groundbreaking findings and stimulate dialogue among researchers, clinicians, and students alike. It is easily accessible to a global audience, embodying the principles of open access, making valuable research available to all. For anyone seeking to stay at the forefront of ophthalmology, CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY is an indispensable resource that fosters knowledge and innovation in the ever-evolving landscape of eye care.
JAMA Ophthalmology
Pioneering Insights in OphthalmologyJAMA Ophthalmology, the premier journal in the field of ophthalmology, is published by the esteemed American Medical Association. Renowned for its rigorous peer-review process and commitment to advancing eye health research, JAMA Ophthalmology holds a prestigious position in the scientific community, boasting an impressive impact factor and ranking as Q1 in the category of Ophthalmology. With a Scopus rank of #3 out of 137 in its field and a remarkable 98th percentile, the journal serves as an invaluable resource for researchers, healthcare professionals, and students dedicated to the ophthalmic sciences. Readers can explore a wealth of cutting-edge findings, clinical studies, and review articles that not only contribute to the sustainable advancement of ophthalmic knowledge but also foster innovative approaches in patient care. As we converge into 2024, the journal continues to embrace open access principles, ensuring that groundbreaking research is readily available to a global audience, enhancing collaborative efforts and furthering the development of the ophthalmology discipline.
Saudi Journal of Ophthalmology
Enhancing Outcomes: Dedicated to the Science of Eye CareSaudi Journal of Ophthalmology, published by Wolters Kluwer Medknow Publications, stands as a crucial platform for the dissemination of innovative research and clinical practices in the field of ophthalmology. Since its inception in 2009, this journal has effectively contributed to the growing body of knowledge with a focus on addressing the diverse visual health challenges faced globally. With an ISSN of 1319-4534 and a E-ISSN of 2542-6680, the journal is indexed in Scopus, where it ranks in the Q3 category of ophthalmology, reflecting its commitment to quality research despite the competitive landscape. Situated in India, it provides a unique regional perspective while facilitating global discourse among researchers, practitioners, and students in ophthalmological sciences. Although it currently does not operate as an open-access journal, the Saudi Journal of Ophthalmology is essential for those aiming to expand their understanding of advancements in eye care, making it a valuable resource for professionals dedicated to enhancing patient outcomes through informed research and clinical practice.
JOURNAL FRANCAIS D OPHTALMOLOGIE
Connecting professionals to the latest in vision care advancements.JOURNAL FRANCAIS D OPHTALMOLOGIE, published by MASSON EDITEUR, is a prominent peer-reviewed journal that serves as a vital resource in the field of ophthalmology. Launched in 1978, this esteemed publication continues to make significant contributions to the advancement of ocular health and vision science, with its scope encompassing clinical practices, innovative research, and the latest technological advancements in ophthalmic care. Based in France, the journal is recognized in the 2023 category quartiles with a Q3 ranking in ophthalmology, reflecting its dedication to quality scholarship within a competitive landscape, as evidenced by its positioning in the 30th percentile of the Scopus rankings. While it operates without Open Access, the journal remains crucial for professionals, researchers, and students alike, providing a platform for sharing knowledge and fostering collaborations in the global ophthalmological community.